Serum Anti-Müllerian Hormone (AMH) as a Predictor of Ovarian Response and Individual Cycle Outcome in Women Undergoing Repetitive Egg Donation Cycles

      Background: AMH measurement is increasingly being used for the prediction of the extremes in ovarian response to gonadotropin stimulation during IVF. Previous studies have suggested that serum AMH is a good predictor of ovarian reserve, has minimal cycle day-to-day variability, and is not affected by GnRH agonists, making it ideal for IVF.
      To read this article in full you will need to make a payment


      Subscribe to Fertility and Sterility
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect